ImmunityBio, Inc. (IBRX)

Healthcare · Biotechnology · NASDAQ

ImmunityBio, Inc. (IBRX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $9.85B and a free-cash-flow yield of -3.7%. Over the most recent reported fiscal year, revenue grew 668.3%.

Market cap	$9.85B
Trailing P/E	—
FCF yield	-3.7%
Revenue growth (YoY)	+668.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live IBRX data on Nama Insights →